Provided by Tiger Trade Technology Pte. Ltd.

Akero Therapeutics

54.65
0.0000
Volume:- -
Turnover:836.20M
Market Cap:4.50B
PE:-14.61
High:54.65
Open:54.65
Low:54.65
Close:54.65
52wk High:58.40
52wk Low:21.34
Shares:82.32M
Float Shares:67.77M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7418
EPS(LYR):-3.7544
ROE:-34.53%
ROA:-22.63%
PB:4.70
PE(LYR):-14.56

Loading ...

Akero Therapeutics downgraded to Hold from Buy at Canaccord

TIPRANKS
·
Oct 09, 2025

Akero Therapeutics rises 16.5%

TIPRANKS
·
Oct 09, 2025

BREAKINGVIEWS-Novo Nordisk’s liver deal misses bigger ailment

Reuters
·
Oct 09, 2025

Sector Update: Health Care Stocks Mixed Pre-Bell Thursday

MT Newswires Live
·
Oct 09, 2025

Novo Nordisk Exec Says Co Will Be Open to More Innovative Deals -Conf Call

THOMSON REUTERS
·
Oct 09, 2025

Novo Nordisk to Acquire Akero Therapeutics to Expand MASH Portfolio

TIPRANKS
·
Oct 09, 2025

BUZZ-U.S. STOCKS ON THE MOVE-Novo Nordisk, Oracle, Delta Air Lines

Reuters
·
Oct 09, 2025

Novo Nordisk is paying up to $5.2 billion for a San Francisco biotech working on liver disease

Dow Jones
·
Oct 09, 2025

Akero Therapeutics Rockets 19% as Novo Nordisk to Buy It for up to $5.2 Billion

Reuters
·
Oct 09, 2025

Akero Therapeutics jumps 18% to $54.74 after Novo Nordisk buyout offer

TIPRANKS
·
Oct 09, 2025

Akero Therapeutics Shares Rise 16.7% Premarket After Novo Nordisk to Acquire Co for up to $5.2 Billion

THOMSON REUTERS
·
Oct 09, 2025

Akero Therapeutics Inc - Shareholders to Receive $54 per Share in Cash

THOMSON REUTERS
·
Oct 09, 2025

Akero Therapeutics to Be Acquired by Novo Nordisk for up to $5.2 Billion

THOMSON REUTERS
·
Oct 09, 2025

Novo Nordisk to acquire Akero Therapeutics for 47 billion USD plus potential milestone payment

Reuters
·
Oct 09, 2025

NOVO NORDISK - TRANSACTION WILL BE MAINLY DEBT FINANCED

THOMSON REUTERS
·
Oct 09, 2025

Akero Therapeutics Announces New Phase 2b Clinical Data for Efruxifermin in MASH at Upcoming AASLD 2025 Liver Meeting

Reuters
·
Oct 07, 2025

Akero Therapeutics COO Jonathan Young Reports Disposal of Common Shares

Reuters
·
Oct 04, 2025

Akero Therapeutics Announces Full Prepayment of $37.6 Million Loan, Terminates Debt Agreement with Hercules Capital

Reuters
·
Sep 30, 2025

Akero Therapeutics (AKRO) Receives a Buy from Canaccord Genuity

TIPRANKS
·
Sep 19, 2025

Strategic Value and Market Positioning Drive Buy Rating for Akero Therapeutics

TIPRANKS
·
Sep 18, 2025